TRANSVAC is a collaborative infrastructure project funded by the European Commission, initially under the 7th Framework Programme and currently under Horizon 2020. The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative. TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development. The TRANSVAC2 Consortium has set up training modules at leading European centres (in collaboration with WP18 partners) that can be combined to create customised international courses on vaccine R&D. In October, three of these training modules take place at Fraunhofer IME, Aachen Germany.
M10 - Assay Development and Validation-Application of SPR Technologies in Vaccine development and manufacturing.
Date: 10-11 October 2019
M11 - Process Development and scale-up of recombinant protein vaccines.
Date: 7-8 October 2019
M12 - Requirements for GMP production
Date: 14-15 October 2019
Submission deadline: 1st July 2019
Applicants can apply for all training via one application form!
Notification of application outcome: 1st August 2019
More information on the call and the application form can be found here.